Coffee after surgery: a simple sip to speed bowel recovery?

NCT ID NCT07686510

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This trial investigates whether drinking coffee after laparoscopic hysterectomy helps the bowels start working again sooner and reduces time spent in the hospital. Women who have the surgery are randomly assigned to receive either standard care plus coffee at set times or standard care alone. The study measures how quickly they pass gas, have a bowel movement, and are discharged.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
coffee
What this could lead to
If it works, this could offer a simple, low-cost way to help women recover faster after hysterectomy.
What could go wrong
This is a small, early-stage trial with only 50 participants, so results may not apply broadly. Coffee may not speed recovery for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

May 2025

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women aged 18 years or older. * Scheduled for elective laparoscopic hysterectomy. * Able to consume oral fluids according to the ERAS protocol. * Able to communicate in Turkish. * Willing to participate and provide written informed consent. Exclusion Criteria: * Emergency surgery. * Known allergy or intolerance to coffee or caffeine. * Gastrointestinal diseases or conditions affecting bowel motility. * Postoperative complications requiring intensive care or preventing oral intake. * Withdrawal of informed consent at any stage of the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gastrointestinal motility disorder are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Istanbul Bağcılar Training and Research Hospital

    Istanbul, 34810, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.